CureVac to Present First CVGBM Glioblastoma Cancer Vaccine Clinical Data at ESMO 2024 Congress
TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / September 9, 2024 / CureVac N.V. (Nasdaq:CVAC) ("CureVac"), a global biopharmaceutical company...
Cancer
NeoImmuneTech Presents Promising Interim Results of CAR-T Combination with its NT-I7 Asset at ESMO 2024
Adequate cell expansion and persistence remains a key challenge that limits the efficacy of chimeric antigen receptor T (CAR-T) cell therapiesNew...
MGI Launches New Nanopore Sequencing Products with Advanced CycloneSEQ Technology
SHENZHEN, China, Sept. 9, 2024 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and...
Roche advances AI-driven cancer diagnostics by expanding its digital pathology open environment
The Roche Digital Pathology Open Environment brings together a wide array of innovative AI-based pathology tools to help clinicians improve...
Hemogenyx Pharmaceuticals PLC – FLT3 Assay Ready for Phase I Trials at MD Anderson
LONDON, UNITED KINGDOM / ACCESSWIRE / September 9, 2024 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), a clinical-stage biopharmaceutical group focused on...
Cantargia: New Data from Two Clinical Studies Strongly Support Nadunolimab Efficacy After Relapse on PD1-Inhibitors
LUND, SE / ACCESSWIRE / September 8, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm:CANTA) today reported data from...
Brain Buddy AI Partners with Learn Look Locate to Expand Global Breast Cancer Awareness
NEW YORK, Sept. 6, 2024 /PRNewswire/ -- Brain Buddy AI, a leader in AI-driven marketing solutions for small to medium-sized...
“SOCIAL GOOD” STUDENT ENTREPRENEURS FROM UNIVERSITY OF PITTSBURGH WIN PRESTIGIOUS $1 MILLION 2024 HULT PRIZE
KORION HEALTH DEVELOPING AI-DRIVEN SCREENING TOOLS, EMPOWERING PATIENTS TO MONITOR HEALTHCARE FROM HOME LONDON and CAMBRIDGE, Mass., Sept. 6, 2024...
Body Vision Medical Featured in Scientific Abstract, Will Showcase Latest Software at the 2024 European Respiratory Society Congress
WESTON, Mass., Sept. 6, 2024 /PRNewswire/ -- Body Vision Medical, a leader in AI-driven, intraoperative imaging, announced today that its...
Oncolytics Biotech® to Participate in Fireside Chats at Two Investment Conferences in September
SAN DIEGO and CALGARY, AB, Sept. 6, 2024 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing...
Weekly Recap: 10 Health Press Releases You Might Have Missed
A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including a new COVID-19 vaccine, Prostate...
Sectra’s three-month interim report 2024/2025: Increased recurring revenue led to a strong first quarter
LINKÖPING, Sweden, Sept. 6, 2024 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) is continuing to...
Prosthetic Robot Arm Market to Grow by USD 640 Million from 2024-2028 as Rising Amputation Cases Drive Revenue, AI Revolutionizing Market Landscape – Technavio Report
NEW YORK, Sept. 5, 2024 /PRNewswire/ -- Report with market evolution powered by AI- The global prosthetic robot arm market size...
Gladstone Institutes Launches Capital Campaign to Accelerate a Biomedical Revolution
The $350 million Gladstone NOW campaign will raise funds to expand Gladstone's footprint, hire hundreds of additional scientists, and seize...
New Treatments in Development Offer Hope for Thousands of Canadian Pulmonary Fibrosis (PF) Patients After Nearly a Decade of Anticipation
With ongoing investigation into PF and other diseases that inflame and permanently scar lung tissue, researchers are hoping to stop...
Ovation.io and PD Theranostics (PDTx) Complete Merger Creating a Multiomic Data Company Which Owns a Unique Population-Scale Biobank of Disease-Specific Biospecimens
Ovation owns a unique population-scale biobank of consented and linkable disease-specific biospecimens, which includes more than 1.6 million samples from...
Lucius Partners Portfolio Company, PD Theranostics, Completes its Merger with Ovation.io Creating a Multiomic Data Company Which Owns a Unique Population-Scale Biobank of Disease-Specific Biospecimens
Ovation owns a unique population-scale biobank of consented and linkable disease-specific biospecimens, which includes more than 1.6 million samples from over...
BIZCLIK MEDIA LAUNCHES SEPTEMBER EDITION OF HEALTHCARE DIGITAL
The September edition of Healthcare Digital includes exclusive interviews with leading experts and executives from Oklahoma Cancer Specialists & Research...
Learn More About Food Safety This National Food Safety Education Month
SILVER SPRING, Md., Sept. 5, 2024 /PRNewswire/ -- September is National Food Safety Education Month. The U.S. Food and Drug Administration...
Sequentify and Dexter Collaborate to Introduce Genomic Sequencing Solutions to the Romanian Market
REHOVOT, Israel, Sept. 5, 2024 /PRNewswire/ -- Sequentify has partnered with Dexter, a Romanian distributor, to bring Sequentify's InfiniSeq™ library...